EGFR is an upstream component of the PI3K/mTOR signaling pathway in human neoplasms and is overexpressed in numerous malignant carcinomas (such as breast cancer, gastrointestinal adenocarcinoma, colorectal cancer, and lung cancer [36–39]) and indicates poor prognosis of cancer [40]. Here, MTOR is linked to breast cancer.